1. |
杨凯转, 闫淑, 邵玲, 等. 新型冠状病毒感染相关视网膜疾病的多模式影像特征分析[J]. 中华眼底病杂志, 2023, 39(3): 194-198. DOI: 10.3760/cma.j.cn511434-20221230-00676.Yang KZ, Yan S, Shao L, et al. Multimodal imaging characteristics of retinal diseases associated with COVID-19[J]. Chin J Ocul Fundus Dis, 2023, 39(3): 194-198. DOI: 10.3760/cma.j.cn511434-20221230-00676.
|
2. |
Stroh I, Nguyen A, Channa R. Purtscher-like retinopathy in hemolytic uremic syndrome[J/OL]. JAMA Ophthalmol, 2019, 137(1): e183911[2019-01-01]. https://pubmed.ncbi.nlm.nih.gov/30629118/. DOI: 10.1001/jamaophthalmol.2018.3911.
|
3. |
Miguel AI, Henriques F, Azevedo LF, et al. Systematic review of purtscher’s and purtscher-like retinopathies[J]. Eye (Lond), 2013, 27(1): 1-13. DOI: 10.1038/eye.2012.222.
|
4. |
Ishibashi T, Wakabayashi T, Nishida K. Purtscher-like retinopathy associated with systemic lupus erythematosus observed using wide-field OCT angiography[J]. Ophthalmol Retina, 2019, 3(1): 76. DOI: 10.1016/j.oret.2018.07.015.
|
5. |
Narang S, Aggarwal P, Bhattacharyya A, et al. Acute pancreatitis presenting as purtscher-like retinopathy[J]. Pancreatology, 2022, 22(2): 333-334. DOI: 10.1016/j.pan.2022.01.005.
|
6. |
Pinto C, Fernandes T, Gouveia P, et al. Purtscher-like retinopathy: ocular findings in a young woman with chronic kidney disease[J/OL]. Am J Ophthalmol Case Rep, 2022, 25: 101301[2022-01-24]. https://pubmed.ncbi.nlm.nih.gov/35146191/. DOI: 10.1016/j.ajoc.2022.101301.
|
7. |
Garcia-Soler E, Martinez-Rubio C, De Smet MD, et al. Systemic lupus erythematosus purtscher like retinopathy: optical coherence tomography angiography assessment implications[J]. Eur J Ophthalmol, 2024, 34(1): 75-79. DOI: 10.1177/112067 21231171705.
|
8. |
Dammacco R. Systemic lupus erythematosus and ocular involvement: an overview[J]. Clin Exp Med, 2018, 18(2): 135-149. DOI: 10.1007/s10238-017-0479-9.
|
9. |
Serhan HA, Abuawwad MT, Taha MJJ, et al. Purtscher's and Purtscher-like retinopathy etiology, features, management, and outcomes: a summative systematic review of 168 cases[J/OL]. PLoS One, 2024, 19(9): e0306473[2024-09-06]. https://pubmed.ncbi.nlm.nih.gov/39240905/. DOI: 10.1371/journal.pone.0306473.
|
10. |
Chaili S, Mok A, Adrean SD. Purtscher-like retinopathy following total knee arthroplasty: a report of 2 cases[J/OL]. Am J Ophthalmol Case Rep, 2020, 20: 100945[2020-10-02]. https://pubmed.ncbi.nlm.nih.gov/33083634/. DOI: 10.1016/j.ajoc.2020.100945.
|
11. |
Rahman EZ, Shah P, Ong JE, et al. Purtscher-like retinopathy in a patient with COVID-19 and disseminated intravascular coagulation[J/OL]. Am J Ophthalmol Case Rep, 2021, 24: 101229[2021-11-11]. https://pubmed.ncbi.nlm.nih.gov/34796309/. DOI: 10.1016/j.ajoc.2021.101229.
|
12. |
Wu C, Dai R, Dong F, et al. Purtscher-like retinopathy in systemic lupus erythematosus[J]. Am J Ophthalmol, 2014, 158(6): 1335-1341. DOI: 10.1016/j.ajo.2014.09.001.
|
13. |
Meng L, Yu Q, Zhao X, et al. Purtscher-like retinopathy in systemic lupus erythematosus: clinical features, risk factors and prognosis[J]. QJM, 2023, 116(11): 923-932. DOI: 10.1093/qjmed/hcad204.
|
14. |
Shoughy SS, Tabbara KF. Ocular findings in systemic lupus erythematosus[J]. Saudi J Ophthalmol, 2016, 30(2): 117-121. DOI: 10.1016/j.sjopt.2016.02.001.
|
15. |
Luboń W, Luboń M, Kotyla P, et al. Understanding ocular findings and manifestations of systemic lupus erythematosus: update review of the literature[J/OL]. Int J Mol Sci, 2022, 23(20): 12264[2022-10-14]. https://pubmed.ncbi.nlm.nih.gov/36293119/. DOI: 10.3390/ijms232012264.
|
16. |
Li B, Li D, Chen Y. Purtscher-like retinopathy presented a honeycomb-like pattern in optical coherence topography angiography[J]. BMC Ophthalmol, 2019, 19(1): 232. DOI: 10.1186/s12886-019-1233-8.
|
17. |
王波, 张玉洁, 靳睿, 等. Purtscher样视网膜病变的临床观察[J]. 眼科学报, 2023, 38(5): 387-393. DOI: 10.12419/j.issn.1000-4432.2023.05.04.Wang B, Zhang YJ, Jin R, et al. Clinical observation of Purtscher-like retinopathy[J]. Eye Science, 2023, 38(5): 387-393. DOI: 10.12419/j.issn.1000-4432.2023.05.04.
|
18. |
Li M, Jin Y, He J. Purtscher-like retinopathy associated with systemic lupus erythematosus treated with rituximab plus low-dose interleukin-2: a case report[J]. Int J Rheum Dis, 2023, 26(7): 1373-1376. DOI: 10.1111/1756-185X.14623.
|